Literature DB >> 1120613

Lymphocyte responses to rubella antigen and phytohemagglutinin after administration of the RA 27/3 strain of live attenuated rubella vaccine.

T Vesikari, E Buimovici-Klein.   

Abstract

Lymphocyte phytohemagglutinin (PHA) responsiveness was found suppressed in both rubella sero-negative and sero-positive recipients of RA 27/3 strain of live attenuated rubella vaccine; the suppression was readily demonstrable only when a suboptimal dose of PHA was applied in the test. Lymphocytes from sero-negative vaccinees, which initially showed little or no in vitro response to concentrated rubella virus, became responsive after vaccination by day 21, when the highest sensitization to rubella antigen was seen. In the sero-positive vaccinees. lymphocytes responded to rubella antigen in vitro before vaccination, and in most cases vaccination did not result in significant changes in lymphocyte response. These results suggest that rubella vaccination leads to temporarily increased lymphocyte reactivity to rubella antigen, and the increased lymphocyte response to specific antigen may occur at the time of mild suppression of PHA response.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1120613      PMCID: PMC415132          DOI: 10.1128/iai.11.4.748-753.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Recovery of rubella virus from army recruits.

Authors:  P D PARKMAN; E L BUESCHER; M S ARTENSTEIN
Journal:  Proc Soc Exp Biol Med       Date:  1962-10

2.  Evidence for a macrophage-mediated effect of poliovirus on the lymphocyte response to phytohemagglutinin.

Authors:  F J Soontiëns; J van der Veen
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

3.  Ethnicity is a significant factor in the epidemiology of rubella and Hodgkin's disease.

Authors:  M C Honeyman; M A Menser
Journal:  Nature       Date:  1974-10-04       Impact factor: 49.962

4.  Suppression of the response of lymphocytes to phytohemagglutinin in rubella.

Authors:  L E McMorrow; T Vesikari; S R Wolman; J P Giles; L Z Cooper
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

5.  Rubella virus and human lymphocytes in culture.

Authors:  M J Simons; M G Fitzgerald
Journal:  Lancet       Date:  1968-11-02       Impact factor: 79.321

6.  Development of specific cellular and humoral immune responses in children immunized with live rubella virus vaccine.

Authors:  R W Steele; S A Hensen; M M Vincent; D A Fuccillo; J A Bellanti
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

7.  Lymphoblast proliferation and humoral antibody response after rubella vaccination.

Authors:  M Lalla; T Vesikari; M Virolainen
Journal:  Clin Exp Immunol       Date:  1973-10       Impact factor: 4.330

8.  A differential effect of IgM and IgG antibodies on the blastogenic response of lymphocytes to rubella virus.

Authors:  J C Lee; M M Sigel
Journal:  Cell Immunol       Date:  1974-07       Impact factor: 4.868

9.  The relationship between rubella hemagglutination inhibition antibody (HIA) and rubella induced in vitro lymphocyte tritiated thymidine incorporation.

Authors:  K A Smith; L Chess; M R Mardiney
Journal:  Cell Immunol       Date:  1973-08       Impact factor: 4.868

10.  Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers.

Authors:  C A Kauffman; J P Phair; C C Linnemann; G M Schiff
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

View more
  18 in total

1.  Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C.

Authors:  H H Chaye; C A Mauracher; A J Tingle; S Gillam
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

2.  Rubella virus and rheumatoid arthritis.

Authors:  H Hart; B P Marmion
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

3.  Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Nathaniel D Lambert; V Shane Pankratz; Gregory A Poland
Journal:  Hum Genet       Date:  2014-08-07       Impact factor: 4.132

4.  The nerve deaf child--intrauterine rubella or not?

Authors:  C S Hosking; C Pyman; B Wilkins
Journal:  Arch Dis Child       Date:  1983-05       Impact factor: 3.791

5.  Rubella virus-specific cytotoxic T-lymphocyte responses: identification of the capsid as a target of major histocompatibility complex class I-restricted lysis and definition of two epitopes.

Authors:  A E Lovett; C S Hahn; C M Rice; T K Frey; J S Wolinsky
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

6.  Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice.

Authors:  R J Klein; A E Friedman-Kien; A A Fondak; E Buimovici-Klein
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

7.  Sequential changes in cell-mediated immune responses to herpes simplex virus after recurrent herpetic infection in humans.

Authors:  E J Shillitoe; J M Wilton; T Lehner
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

8.  Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.

Authors:  E Rossier; P H Phipps; J R Polley; T Webb
Journal:  Can Med Assoc J       Date:  1977-03-05       Impact factor: 8.262

9.  Rubella-specific immune complexes after congenital infection and vaccination.

Authors:  P K Coyle; J S Wolinsky; E Buimovici-Klein; R Moucha; L Z Cooper
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

10.  Analysis of T- and B-cell epitopes of capsid protein of rubella virus by using synthetic peptides.

Authors:  D Ou; P Chong; B Tripet; S Gillam
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.